Cargando…

Effective in vitro delivery of paclitaxel by nanocargo of mesoporous polycaprolactone against triple negative breast cancer cells by minimalizing drug dose

Among the breast cancers, triple negative breast cancer (TNBC) has relatively poor outcomes with a lower survival rate and personalised chemotherapy is the only option available for treatment. Currently in the biomedical domain, nanomaterials with porous morphology have revealed their tremendous pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medhi, Himadri, Khumukcham, Saratchandra Singh, Manavathi, Bramanandam, Paik, Pradip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055105/ https://www.ncbi.nlm.nih.gov/pubmed/35517325 http://dx.doi.org/10.1039/d0ra04505e

Ejemplares similares

Reversible glycosidic switch for secure delivery of molecular nanocargos
por: Burnouf, Pierre-Alain, et al.
Publicado: (2018)

HPIP and RUFY3 are noncanonical guanine nucleotide exchange factors of Rab5 to regulate endocytosis-coupled focal adhesion turnover
por: Khumukcham, Saratchandra Singh, et al.
Publicado: (2023)

Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System
por: Sudhakar, Kalvatala, et al.
Publicado: (2021)

Amino acid starvation sensing dampens IL-1β production by activating riboclustering and autophagy
por: Battu, Srikanth, et al.
Publicado: (2018)

Oestrogen receptor negativity in breast cancer: a cause or consequence?
por: Gajulapalli, Vijaya Narasihma Reddy, et al.
Publicado: (2016)

MTA family of coregulators in nuclear receptor biology and pathology
por: Manavathi, Bramanandam, et al.
Publicado: (2007)

Tailoring Surface Opening of Hollow Nanocubes and Their Application as Nanocargo Carriers
por: Lu, Fang, et al.
Publicado: (2018)

Prussian blue nanoparticles as nanocargoes for delivering DNA drugs to cancer cells
por: Wang, Shao-Jen, et al.
Publicado: (2013)

Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development
por: Manavathi, Bramanandam, et al.
Publicado: (2014)

Niclosamide loaded biodegradable chitosan nanocargoes: an in vitro study for potential application in cancer therapy
por: Naqvi, Saba, et al.
Publicado: (2017)

Isolation and biological evaluation of N-(4-aminocyclooctyl)-3, 5-dinitrobenzamide, a new semisynthetic derivative from the Mangrove-associated actinomycete Pseudonocardia endophytica VUK-10
por: Mangamuri, Usha Kiranmayi, et al.
Publicado: (2016)

PLGA/nHA hybrid nanofiber scaffold as a nanocargo carrier of insulin for accelerating bone tissue regeneration
por: Haider, Adnan, et al.
Publicado: (2014)

Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitis
por: Zeeshan, Mahira, et al.
Publicado: (2023)

Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
por: Sophia, Josephraj, et al.
Publicado: (2018)

Cefazolin-Loaded Double-Shelled Hollow Mesoporous Silica Nanoparticles/Polycaprolactone Nanofiber Composites: A Delivery Vehicle for Regenerative Purposes
por: Karimi, Negar, et al.
Publicado: (2023)

Dose-dense paclitaxel plus carboplatin vs. epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer
por: Li, Qing, et al.
Publicado: (2020)

Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
por: Sezer, Gülay, et al.
Publicado: (2022)

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
por: Liu, Yuetong, et al.
Publicado: (2023)

Recent Advances in Polycaprolactones for Anticancer Drug Delivery
por: Bhadran, Abhi, et al.
Publicado: (2023)

Enhanced biocompatibility and osteogenic potential of mesoporous magnesium silicate/polycaprolactone/wheat protein composite scaffolds
por: Kang, Yun Gyeong, et al.
Publicado: (2018)

Targeted Delivery of Paclitaxel in Liver Cancer Using Hyaluronic Acid Functionalized Mesoporous Hollow Alumina Nanoparticles
por: Gao, Yu, et al.
Publicado: (2019)

Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
por: Chen, Tianyu, et al.
Publicado: (2022)

Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer
por: Guo, Beibei, et al.
Publicado: (2023)

Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer
por: Qi, Yanfeng, et al.
Publicado: (2012)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2021)

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
por: Blanchard, Zannel, et al.
Publicado: (2015)

Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
por: Arpino, Grazia, et al.
Publicado: (2015)

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
por: Huang, Liang, et al.
Publicado: (2017)

Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
por: Wang, Longkun, et al.
Publicado: (2023)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Flexible Polycaprolactone and Polycaprolactone/Graphene Scaffolds for Tissue Engineering
por: Evlashin, Stanislav, et al.
Publicado: (2019)

SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
por: Liu, Xi-Yu, et al.
Publicado: (2020)

Effect of Ect2 Expression on the Growth of Triple-Negative Breast Cancer Cells with Paclitaxel Intervention
por: Wang, Hongkun, et al.
Publicado: (2020)

Molecular Imaging of Oxygenation Changes during Immunotherapy in Combination with Paclitaxel in Triple Negative Breast Cancer
por: Napier, Tiara S., et al.
Publicado: (2023)

Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
por: Ye, Jun, et al.
Publicado: (2016)

Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
por: Meng, Huan, et al.
Publicado: (2015)

Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
por: Gupta, Ajay
Publicado: (2012)

Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2022)

Characterization and osteogenic evaluation of mesoporous magnesium–calcium silicate/polycaprolactone/polybutylene succinate composite scaffolds fabricated by rapid prototyping
por: Kang, Yun Gyeong, et al.
Publicado: (2018)

Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
por: Kim, Jean, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hektk0l6c0srgbct5g99gu1kcs